Skip to content
10-Q

Quarterly Report

ANTIVIRAL TECHNOLOGIES, INC.

0001137050-11-000213

← back to feed
Filed
Aug 15, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Jun 30, 2011 150M sh
Operating Cash Flow Q2 2011 · Jun 30, 2011 −$953.17K
Operating Cash Flow Q2 2011 · Jun 30, 2010 −$43.89K
Cash And Equivalents Q2 2011 · Jun 30, 2011 $7.27K
Cash And Equivalents Q2 2011 · Jun 30, 2010 $2.59K
Stockholders Equity Q2 2011 · Jun 30, 2011 −$1.71M
Stockholders Equity Q2 2011 · Dec 31, 2010 −$1.52M
Total Liabilities Q2 2011 · Jun 30, 2011 $2.11M
Total Liabilities Q2 2011 · Dec 31, 2010 $1.91M
Current Assets Q2 2011 · Jun 30, 2011 $8.81K
Current Assets Q2 2011 · Dec 31, 2010 $11.03K
Total Assets Q2 2011 · Jun 30, 2011 $397.19K
Total Assets Q2 2011 · Dec 31, 2010 $384.22K
Sga Expense Q2 2011 · Jun 30, 2011 $1.55M
Sga Expense Q2 2011 · Jun 30, 2010 $96.91K
Sga Expense Q2 2011 · Jun 30, 2010 $204.61K
Net Income Q2 2011 · Jun 30, 2011 −$1.72M
Net Income Q2 2011 · Jun 30, 2010 −$96.91K
Net Income Q2 2011 · Jun 30, 2010 −$205.58K